Skip to main navigation Skip to search Skip to main content

Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes

R Rabøl, R Boushel, T Almdal, C N Hansen, T Ploug, S B Haugaard, C Prats, S Madsbad, F Dela

42 Citations (Scopus)

Abstract

Skeletal muscle insulin resistance has been linked to mitochondrial dysfunction. We examined how improvements in muscular insulin sensitivity following rosiglitazone (ROSI) or pioglitazone (PIO) treatment would affect muscle mitochondrial function in patients with type 2 diabetes mellitus (T2DM).
Original languageEnglish
JournalDiabetic Medicine
Volume12
Issue number9
Pages (from-to)806-14
Number of pages8
ISSN0742-3071
DOIs
Publication statusPublished - 2010

Keywords

  • Body Mass Index
  • Cell Respiration
  • Diabetes Mellitus, Type 2
  • Female
  • Hemoglobin A, Glycosylated
  • Humans
  • Hypoglycemic Agents
  • Immunohistochemistry
  • Insulin Resistance
  • Male
  • Middle Aged
  • Mitochondria, Muscle
  • Muscle, Skeletal
  • Thiazolidinediones

Fingerprint

Dive into the research topics of 'Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes'. Together they form a unique fingerprint.

Cite this